MEDTRONIC ENTERS CSF SHUNT MARKET THROUGH PS MEDICAL ACQUISITION; STOCK-FOR- STOCK TRANSACTION ALSO COULD FILL OUT DRUG DELIVERY SYSTEM OFFERINGS
Medtronic is tapping into the cerebrospinal fluid (CSF) shunt market with the acquisition of PS Medical of Goleta, California in a stock-for-stock deal. Financial terms of the pact, announced Oct. 12, were not disclosed.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
